We observed little support for an association of gene variants in hormone receptors (ESR1, ESR2, PGR) and active estrogen synthesizers (HSD17B1, HSD17B2, and HSD17B4) with colorectal cancer risk among postmenopausal women of European descent. Here, NR4A1 is linked to colorectal cancer.